Biochem/physiol Actions
VX-702 is a second generation p38α MAPK inhibitor with 14-fold higher potency against p38α versus p38β.
Republic of Ireland +353(0)1 4069464
Northern Ireland +44(0) 28 9262 1100
England & Wales +44(0) 115 982 1111
Scotland +44(0) 1236 431 857
WARNING
Please enter the email address of the person you would like to share this basket with.
Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.